{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:50:26Z","timestamp":1794646226415,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971811"],"award-info":[{"award-number":["81971811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802095"],"award-info":[{"award-number":["81802095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602910"],"award-info":[{"award-number":["81602910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972729"],"award-info":[{"award-number":["81972729"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technological Supports Project of Sichuan Province, China","award":["2017FZ0043"],"award-info":[{"award-number":["2017FZ0043"]}]},{"name":"Science and Technological Supports Project of Sichuan Province, China","award":["2019YFS0372"],"award-info":[{"award-number":["2019YFS0372"]}]},{"name":"Science and Technological Supports Project of Sichuan Province, China","award":["2019YFS0370"],"award-info":[{"award-number":["2019YFS0370"]}]},{"name":"Science and Technological Supports Project of Sichuan Province, China","award":["2020YFS0203"],"award-info":[{"award-number":["2020YFS0203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>As one of the most malignant cancer types, hepatocellular carcinoma (HCC) is highly invasive and capable of metastasizing to distant organs. Intermedin (IMD), an endogenous peptide belonging to the calcitonin family, has been suggested playing important roles in cancer cell survival and invasion, including in HCC. However, how IMD affects the behavior of HCC cells and the underlying mechanisms have not been fully elucidated. Here, we show that IMD maintains an important homeostatic state by activating the ERK1\/2-EGR1 (early growth response 1) signaling cascade, through which HCC cells acquire a highly invasive ability via significantly enhanced filopodia formation. The inhibition of IMD blocks the phosphorylation of ERK1\/2, resulting in EGR1 downregulation and endoplasmic reticulum stress (ER) stress, which is evidenced by the upregulation of ER stress marker DDIT3 (DNA damage-inducible transcript 3). The high level of DDIT3 induces HCC cells into an ER-stress related apoptotic pathway. Along with our previous finding that IMD plays critical roles in the vascular remodeling process that improves tumor blood perfusion, IMD may facilitate the acquisition of increased invasive abilities and a survival benefit by HCC cells, and it is easier for HCC cells to obtain blood supply via the vascular remodeling activities of IMD. According to these results, blockade of IMD activity may have therapeutic potential in the treatment of HCC.<\/jats:p>","DOI":"10.1038\/s41598-020-80066-x","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T18:36:08Z","timestamp":1610476568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1\/2-EGR1\/DDIT3 signaling cascade"],"prefix":"10.1038","volume":"11","author":[{"given":"Fei","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingmiao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong\u2019gang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"80066_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.29486","volume":"67","author":"RS Finn","year":"2018","unstructured":"Finn, R. S. et al. Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: a systematic review and meta-analysis. Hepatology 67, 422\u2013435 (2018).","journal-title":"Hepatology"},{"key":"80066_CR2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","volume":"152","author":"D Sia","year":"2017","unstructured":"Sia, D., Villanueva, A., Friedman, S. L. & Llovet, J. M. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152, 745\u2013761 (2017).","journal-title":"Gastroenterology"},{"key":"80066_CR3","doi-asserted-by":"crossref","unstructured":"McGuire, S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Advances in Nutrition 7, 418\u2013419 (2016).","DOI":"10.3945\/an.116.012211"},{"key":"80066_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix, J., Reig, M. & Sherman, M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150, 835\u2013853 (2016).","journal-title":"Gastroenterology"},{"key":"80066_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","volume":"63","author":"J Bruix","year":"2014","unstructured":"Bruix, J., Gores, G. J. & Mazzaferro, V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 63, 844\u2013855 (2014).","journal-title":"Gut"},{"key":"80066_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.gastro.2013.01.002","volume":"144","author":"V Hernandez-Gea","year":"2013","unstructured":"Hernandez-Gea, V., Toffanin, S., Friedman, S. L. & Llovet, J. M. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology 144, 512\u2013527 (2013).","journal-title":"Gastroenterology"},{"key":"80066_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000481315","volume":"6","author":"CE Costentin","year":"2017","unstructured":"Costentin, C. E. et al. Hepatocellular carcinoma with macrovascular invasion: defining the optimal treatment strategy. Liver Cancer 6, 360\u2013374 (2017).","journal-title":"Liver Cancer"},{"key":"80066_CR8","first-page":"491","volume":"12","author":"DH Yang","year":"2004","unstructured":"Yang, D. H. Metastasis and relapse of hepatocellular carcinoma. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi Chin. J. Hepatol. 12, 491 (2004).","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi Chin. J. Hepatol."},{"key":"80066_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister, S. S. & Weinberg, R. A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell. Biol. 16, 717\u2013727 (2014).","journal-title":"Nat. Cell. Biol."},{"key":"80066_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/514309a","volume":"514","author":"A Bottos","year":"2014","unstructured":"Bottos, A. & Hynes, N. E. Cancer: staying together on the road to metastasis. Nature 514, 309\u2013310 (2014).","journal-title":"Nature"},{"key":"80066_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275\u2013292 (2011).","journal-title":"Cell"},{"key":"80066_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"80066_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11427-014-4701-7","volume":"57","author":"X Ni","year":"2014","unstructured":"Ni, X., Zhang, J., Tang, C. & Qi, Y. Intermedin\/adrenomedullin2: an autocrine\/paracrine factor in vascular homeostasis and disease. Sci. China Life Sci. 57, 781\u2013789 (2014).","journal-title":"Sci. China Life Sci."},{"key":"80066_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1476-5381.2011.01530.x","volume":"166","author":"Y Hong","year":"2012","unstructured":"Hong, Y., Hay, D. L., Quirion, R. & Poyner, D. R. The pharmacology of adrenomedullin 2\/intermedin. Br. J. Pharmacol. 166, 110\u2013120 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"80066_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.2174\/13892037113149990049","volume":"14","author":"D Holmes","year":"2013","unstructured":"Holmes, D., Campbell, M., Harbinson, M. & Bell, D. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP. Curr. Protein Pept. Sci. 14, 294\u2013329 (2013).","journal-title":"Curr. Protein Pept. Sci."},{"key":"80066_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3233\/CBM-150523","volume":"15","author":"XL Wang","year":"2015","unstructured":"Wang, X. L. et al. Association of plasma intermedin levels with progression and metastasis in men after radical prostatectomy for localized prostatic cancer. Cancer Biomark. Sect. A Dis. Mark. 15, 799\u2013805 (2015).","journal-title":"Cancer Biomark. Sect. A Dis. Mark."},{"key":"80066_CR17","first-page":"862158","volume":"2015","author":"YM Lu","year":"2015","unstructured":"Lu, Y. M., Zhong, J. B., Wang, H. Y., Yu, X. F. & Li, Z. Q. The prognostic value of intermedin in patients with breast cancer. Dis. Mark. 2015, 862158 (2015).","journal-title":"Dis. Mark."},{"key":"80066_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1677\/JOE-08-0103","volume":"198","author":"R Morimoto","year":"2008","unstructured":"Morimoto, R. et al. Expression of adrenomedullin 2\/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues. J. Endocrinol. 198, 175\u2013183 (2008).","journal-title":"J. Endocrinol."},{"key":"80066_CR19","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/j.1349-7006.2012.02341.x","volume":"103","author":"X Guo","year":"2012","unstructured":"Guo, X. et al. Intermedin is overexpressed in hepatocellular carcinoma and regulates cell proliferation and survival. Cancer Sci. 103, 1474\u20131480 (2012).","journal-title":"Cancer Sci."},{"key":"80066_CR20","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1016\/j.febslet.2008.03.039","volume":"582","author":"LM Machesky","year":"2008","unstructured":"Machesky, L. M. Lamellipodia and filopodia in metastasis and invasion. FEBS Lett. 582, 2102\u20132111 (2008).","journal-title":"FEBS Lett."},{"key":"80066_CR21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4161\/cam.5.5.17723","volume":"5","author":"A Arjonen","year":"2011","unstructured":"Arjonen, A., Kaukonen, R. & Ivaska, J. Filopodia and adhesion in cancer cell motility. Cell. Adhes. Migr. 5, 421\u2013430 (2011).","journal-title":"Cell. Adhes. Migr."},{"key":"80066_CR22","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1083\/jcb.201704045","volume":"216","author":"G Jacquemet","year":"2017","unstructured":"Jacquemet, G. et al. FiloQuant reveals increased filopodia density during breast cancer progression. J. Cell. Biol. 216, 3387\u20133403 (2017).","journal-title":"J. Cell. Biol."},{"key":"80066_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/ATVBAHA.117.310317","volume":"38","author":"LJ Wang","year":"2018","unstructured":"Wang, L. J. et al. Intermedin enlarges the vascular lumen by inducing the quiescent endothelial cell proliferation. Arterioscler. Thromb. Vasc. Biol. 38, 398\u2013413 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"80066_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcp.10178","volume":"193","author":"G Thiel","year":"2002","unstructured":"Thiel, G. & Cibelli, G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 193, 287\u2013292 (2002).","journal-title":"J. Cell. Physiol."},{"key":"80066_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/mc.22991","volume":"58","author":"LM Zhao","year":"2019","unstructured":"Zhao, L. M. et al. Antitumor Effect of Periplocin in TRAIL-Resistant gastric cancer cells via upregulation of death receptor through activating ERK1\/2-EGR1 pathway. Mol. Carcinog. 58, 1033\u20131045 (2019).","journal-title":"Mol. Carcinog."},{"key":"80066_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/21691401.2018.1543195","volume":"47","author":"QF Xiang","year":"2019","unstructured":"Xiang, Q. F. et al. Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT\/ERK1\/2-EGR1 pathway. Artif. Cells Nanomed. Biotechnol. 47, 83\u201389 (2019).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"80066_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11033-018-4474-3","volume":"46","author":"J Kim","year":"2019","unstructured":"Kim, J. et al. Leptin is a direct transcriptional target of EGR1 in human breast cancer cells. Mol. Biol. Rep. 46, 317\u2013324 (2019).","journal-title":"Mol. Biol. Rep."},{"key":"80066_CR28","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1159\/000445555","volume":"38","author":"L Li","year":"2016","unstructured":"Li, L. et al. Periplocin extracted from cortex periplocae induced apoptosis of gastric cancer cells via the ERK1\/2-EGR1 pathway. Cell. Physiol. Biochem. 38, 1939\u20131951 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"80066_CR29","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.bcp.2011.02.006","volume":"81","author":"S Chbicheb","year":"2011","unstructured":"Chbicheb, S. et al. EGR1 expression: a calcium and ERK1\/2 mediated PPARgamma-independent event involved in the antiproliferative effect of 15-deoxy-Delta 12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells. Biochem. Pharmacol. 81, 1087\u20131097 (2011).","journal-title":"Biochem. Pharmacol."},{"key":"80066_CR30","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1161\/ATVBAHA.112.300185","volume":"32","author":"W Zhang","year":"2012","unstructured":"Zhang, W. et al. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase. Arterioscler. Thromb. Vasc. Biol. 32, 2721\u20132732 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"80066_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.cdd.4401373","volume":"11","author":"S Oyadomari","year":"2004","unstructured":"Oyadomari, S. & Mori, M. Roles of CHOP\/GADD153 in endoplasmic reticulum stress. Cell. Death Differ. 11, 381\u2013389 (2004).","journal-title":"Cell. Death Differ."},{"key":"80066_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1080\/09168451.2019.1574206","volume":"83","author":"S Yano","year":"2019","unstructured":"Yano, S., Wu, S., Sakao, K. & Hou, D. X. Involvement of ERK1\/2-mediated ELK1\/CHOP\/DR5 pathway in 6-(methylsulfinyl)hexyl isothiocyanate-induced apoptosis of colorectal cancer cells. Biosci. Biotechnol. Biochem. 83, 960\u2013969 (2019).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"80066_CR33","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/toxsci\/kfw173","volume":"154","author":"Z Ren","year":"2016","unstructured":"Ren, Z. et al. Endoplasmic reticulum stress induction and ERK1\/2 activation contribute to nefazodone-induced toxicity in hepatic cells. Toxicol. Sci. 154, 368\u2013380 (2016).","journal-title":"Toxicol. Sci."},{"key":"80066_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00418-012-0967-7","volume":"138","author":"FJ Guo","year":"2012","unstructured":"Guo, F. J. et al. XBP1S protects cells from ER stress-induced apoptosis through Erk1\/2 signaling pathway involving CHOP. Histochem. Cell. Biol. 138, 447\u2013460 (2012).","journal-title":"Histochem. Cell. Biol."},{"key":"80066_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1748-1716.2007.01785.x","volume":"192","author":"M Lawrence","year":"2008","unstructured":"Lawrence, M., Shao, C., Duan, L., McGlynn, K. & Cobb, M. H. The protein kinases ERK1\/2 and their roles in pancreatic beta cells. Acta Physiol. (Oxf.) 192, 11\u201317 (2008).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"80066_CR36","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1111\/febs.13598","volume":"283","author":"R Iurlaro","year":"2016","unstructured":"Iurlaro, R. & Munoz-Pinedo, C. Cell death induced by endoplasmic reticulum stress. FEBS J. 283, 2640\u20132652 (2016).","journal-title":"FEBS J."},{"key":"80066_CR37","doi-asserted-by":"publisher","first-page":"11108","DOI":"10.1074\/jbc.M115.645333","volume":"290","author":"T Li","year":"2015","unstructured":"Li, T. et al. DDIT3 and KAT2A proteins regulate TNFRSF10A and TNFRSF10B expression in endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells. J. Biol. Chem. 290, 11108\u201311118 (2015).","journal-title":"J. Biol. Chem."},{"key":"80066_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.2174\/1566524016666160523143937","volume":"16","author":"W Rozpedek","year":"2016","unstructured":"Rozpedek, W. et al. The role of the PERK\/eIF2alpha\/ATF4\/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress. Curr. Mol. Med. 16, 533\u2013544 (2016).","journal-title":"Curr. Mol. Med."},{"key":"80066_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/jb\/mvp166","volume":"146","author":"K Mori","year":"2009","unstructured":"Mori, K. Signalling pathways in the unfolded protein response: development from yeast to mammals. J. Biochem. 146, 743\u2013750 (2009).","journal-title":"J. Biochem."},{"key":"80066_CR40","doi-asserted-by":"publisher","first-page":"a013169","DOI":"10.1101\/cshperspect.a013169","volume":"5","author":"BM Gardner","year":"2013","unstructured":"Gardner, B. M., Pincus, D., Gotthardt, K., Gallagher, C. M. & Walter, P. Endoplasmic reticulum stress sensing in the unfolded protein response. Cold Spring Harb. Perspect. Biol. 5, a013169 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"80066_CR41","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1091\/mbc.10.11.3787","volume":"10","author":"K Haze","year":"1999","unstructured":"Haze, K., Yoshida, H., Yanagi, H., Yura, T. & Mori, K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell. 10, 3787\u20133799 (1999).","journal-title":"Mol. Biol. Cell."},{"key":"80066_CR42","doi-asserted-by":"publisher","first-page":"H1040","DOI":"10.1152\/ajpheart.00404.2009","volume":"297","author":"RS Smith Jr","year":"2009","unstructured":"Smith, R. S. Jr., Gao, L., Bledsoe, G., Chao, L. & Chao, J. Intermedin is a new angiogenic growth factor. Am. J. Physiol. Heart. Circ. Physiol. 297, H1040-1047 (2009).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"issue":"107","key":"80066_CR43","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1152\/japplphysiol.00569.2009","volume":"1985","author":"E Grossini","year":"2009","unstructured":"Grossini, E. et al. Intracoronary intermedin 1\u201347 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and beta-adrenoreceptor-mediated nitric oxide release. J. Appl. Physiol. 1985(107), 1037\u20131050 (2009).","journal-title":"J. Appl. Physiol."},{"key":"80066_CR44","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1074\/jbc.M305332200","volume":"279","author":"J Roh","year":"2004","unstructured":"Roh, J., Chang, C. L., Bhalla, A., Klein, C. & Hsu, S. Y. Intermedin is a calcitonin\/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor\/receptor activity-modifying protein receptor complexes. J. Biol. Chem. 279, 7264\u20137274 (2004).","journal-title":"J. Biol. Chem."},{"key":"80066_CR45","doi-asserted-by":"publisher","first-page":"e35832","DOI":"10.1371\/journal.pone.0035832","volume":"7","author":"HC Muller-Redetzky","year":"2012","unstructured":"Muller-Redetzky, H. C. et al. Intermedin stabilized endothelial barrier function and attenuated ventilator-induced lung injury in mice. PLoS ONE 7, e35832 (2012).","journal-title":"PLoS ONE"},{"key":"80066_CR46","doi-asserted-by":"publisher","first-page":"L837","DOI":"10.1152\/ajplung.90608.2008","volume":"297","author":"U Pfeil","year":"2009","unstructured":"Pfeil, U. et al. Intermedin\/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L837-845 (2009).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"80066_CR47","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1038\/s41467-018-05062-2","volume":"9","author":"F Xiao","year":"2018","unstructured":"Xiao, F. et al. Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses. Nat. Commun. 9, 2644 (2018).","journal-title":"Nat. Commun."},{"key":"80066_CR48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/cvr\/cvr213","volume":"92","author":"M Aslam","year":"2011","unstructured":"Aslam, M. et al. Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1. Cardiovasc. Res. 92, 276\u2013286 (2011).","journal-title":"Cardiovasc. Res."},{"key":"80066_CR49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1476-5381.2011.01540.x","volume":"165","author":"M Aslam","year":"2012","unstructured":"Aslam, M. et al. Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. Br. J. Pharmacol. 165, 208\u2013222 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"80066_CR50","first-page":"589","volume":"59","author":"K Liu","year":"2013","unstructured":"Liu, K. et al. The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat. Clin. Lab. 59, 589\u2013596 (2013).","journal-title":"Clin. Lab."},{"key":"80066_CR51","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1038\/s41598-017-02534-1","volume":"7","author":"D Wang","year":"2017","unstructured":"Wang, D. et al. The \u201cinherent vice\u201d in the anti-angiogenic theory may cause the highly metastatic cancer to spread more aggressively. Sci. Rep. 7, 2365 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80066-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80066-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80066-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T01:47:30Z","timestamp":1670032050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80066-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80066"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80066-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"9 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}